Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurotrophic keratitis.

S Bonini1, P Rama, D Olzi

  • 1Laboratory of Ophthalmology, Interdisciplinary Center for Biomedical Research, University of Rome, Rome, Italy. sbonini@mclink.it

Eye (London, England)
|November 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prospective Multicenter Observational Study of Patients in Shock Treated with Vasopressin: VASOPRES Registry Study Protocol.

Revista espanola de anestesiologia y reanimacion·2025
Same author

Ocular Biomarkers in Alzheimer's Disease: Insights into Early Detection Through Eye-Based Diagnostics - A Literature Review.

La Clinica terapeutica·2024
Same author

Potential <i>in-vitro</i> antioxidant and anti-inflammatory activity of <i>Martynia annua</i> extract mediated Phytosynthesis of MnO<sub>2</sub> nanoparticles.

Heliyon·2024
Same author

Representation of corneal re-innervation following refractive surgery treatments.

Journal francais d'ophtalmologie·2024
Same author

Photo Quiz: Therapeutic Contact Lens-Associated Fungal Keratitis.

Journal of clinical microbiology·2023
Same author

Answer to July 2023 Photo Quiz.

Journal of clinical microbiology·2023
Same journal

Eyelid margin tick masquerading as a naevus in a child.

Eye (London, England)·2026
Same journal

Full-thickness macular penetration by welding laser injury.

Eye (London, England)·2026
Same journal

Incidence and characteristics of newly formed polypoidal lesions in polypoidal choroidal vasculopathy.

Eye (London, England)·2026
Same journal

Traumatic intravitreal egg-shaped hematoma.

Eye (London, England)·2026
Same journal

Rare ocular triad: Goldenhar syndrome with Duane retraction syndrome and optic disc pit.

Eye (London, England)·2026
Same journal

AS-OCT demonstration of anterior capsular delamination in unilateral true exfoliation.

Eye (London, England)·2026
See all related articles

Neurotrophic keratopathy, a corneal disease from trigeminal nerve damage, causes severe vision issues. Early diagnosis and tailored treatments can halt its progression, with future therapies focusing on growth factors.

Area of Science:

  • Ophthalmology
  • Neurology
  • Regenerative Medicine

Background:

  • Neurotrophic keratopathy is a degenerative corneal condition.
  • It stems from impaired trigeminal nerve function.
  • This impairment leads to loss of corneal sensation, causing epithelial defects, ulcers, and perforation.

Purpose of the Study:

  • To review the pathogenesis, diagnosis, and therapeutic strategies for neurotrophic keratopathy.
  • To highlight the importance of accurate clinical assessment for early diagnosis.
  • To discuss future treatment advancements.

Main Methods:

  • Comprehensive review of existing literature on neurotrophic keratopathy.
  • Analysis of diagnostic criteria, including corneal sensitivity and tear film evaluation.

Related Experiment Videos

  • Examination of current and emerging therapeutic interventions.

    • Main Results:

    • Accurate patient history and clinical examination are crucial for diagnosis.
    • Corneal sensitivity testing and tear film assessment are key diagnostic steps.
    • Staged medical and surgical treatments can effectively manage the condition.

    Conclusions:

    • Neurotrophic keratopathy requires prompt diagnosis through detailed clinical evaluation.
    • Treatment should be individualized based on disease severity.
    • Future treatments may involve neuropeptides and growth factors for corneal regeneration.